KA Imaging To Launch Premium Dual-Energy Mobile System at AHRA

Reveal Mobi Pro is in partnership between KAI and with Del Medical

X-ray manufacturer KA Imaging is unveiling its Reveal Mobi Pro dual-energy mobile X-ray system. The product, which is a collaboration with UMG/Del Medical, will be showcased at the upcoming AHRA Annual Meeting.

“This partnership with Del Medical comes at an excellent time,” said Amol Karnick, President and CEO of KA Imaging. “After the pandemic, mobile imaging has become more prominent in many healthcare facilities, so offering a solution to improve the visualization of bones and tissues at the bedside is essential,” said Karnick.

“We are excited to support KA Imaging and their enhanced detector technology for the conventional and mobile radiographic markets,” said Marc Lorenzo, Executive Vice President at Del Medical.

The Reveal Mobi Pro integrates KA Imaging’s Reveal™ 35C detector with SpectralDR™ technology into a complete mobile X-ray solution. Reveal’s ability to simultaneously acquire conventional and dual-energy images with a single exposure at the bedside improves hospital and patient outcomes and protects revenue by reducing outflows.

The Reveal 35C detector mimics the workflow, dose and techniques of state-of-the-art mobile DR X-ray. With the Reveal Mobi Pro, it is offered in a fully integrated mobile system.

Last November, KA Imaging unveiled its first integrated mobile dual-energy X-ray system, Reveal Mobi Lite. The main difference between the Lite and Pro versions are around some advanced features, only available in the Pro system. The most noteworthy feature of the Reveal Mobi Pro is the telescopic arm. In addition to the collapsible column design, the system has a high-frequency 40KW generator, integrated DR Workstation, 8-hour battery life, and motor-assisted movement.

The AHRA Annual Meeting will be held from July 9-12 at Indiana Convention Center. KA Imaging has booth #329.

The Reveal 35C detector is FDA 510(k) cleared. The Reveal Mobi Pro is coming soon and is not available for sale.

Busy year

Earlier this year, the company announced Robert (Bob) Thompson as an executive advisor, bringing 30 plus years of experience in medical devices. Before joining the company, Thompson was the President for Siemens Healthineers Ultrasound. He also held several leadership positions at GE Healthcare.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version